What is Cumberland Pharmaceuticals's D&A?

Cumberland Pharmaceuticals (CPIX) reported D&A of $1.28M in Q1 2026.

How has Cumberland Pharmaceuticals's D&A changed year-over-year?

Cumberland Pharmaceuticals's D&A increased by 23.7% year-over-year, from $1.03M to $1.28M.

What is the long-term trend for Cumberland Pharmaceuticals's D&A?

Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's D&A has grown at a -2.6% compound annual growth rate (CAGR), from $4.61M to $4.15M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Cumberland Pharmaceuticals CPIX D&A

D&A at other companies

Baxter InternationalBAX

$237M-4.0%

PTH

Pelthos Therapeutics Inc.PTHS

$469K—

Rigel PharmaceuticalsRIGL

$597K-1.2%

BridgeBio PharmaBBIO

$1.19M-7.6%

RFL

Rafael Holdings, Inc.RFL

$48K-22.6%

Opko HealthOPK

$22.2M-5.5%

Other financials

Income statement

See full

Revenue$9.1M-22.0%

Gross profit$7.2M-30.0%

Operating income-$3.1M-342%

Net income-$3.3M-362%

EPS (diluted)-$0.22-375%

Balance sheet

See full

Cash & equivalents$11.0M-27.1%

Total debt$4.8M-7.1%

Total equity$21.6M-24.5%

Total assets$71.0M+1.5%

Cash flow

See full

Operating cash flow$387.0K-90.1%

CapEx--100%

Free cash flow$387.0K-89.9%

Valuation

See full

Market cap$97.09M+138%

Enterprise value$90.91M+207%

P/S2.3×+1.3×

Profitability

See full

Gross margin82.9%-1.4pp

Operating margin-17.2%-125pp

Net margin-17.6%-103pp

FCF margin3.3%—

Returns & leverage

See full

Return on equity-29.4%-86.3pp

Debt / equity0.2×0.0×

Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cumberland Pharmaceuticals's D&A?: Cumberland Pharmaceuticals (CPIX) reported D&A of $1.28M in Q1 2026.
How has Cumberland Pharmaceuticals's D&A changed year-over-year?: Cumberland Pharmaceuticals's D&A increased by 23.7% year-over-year, from $1.03M to $1.28M.
What is the long-term trend for Cumberland Pharmaceuticals's D&A?: Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's D&A has grown at a -2.6% compound annual growth rate (CAGR), from $4.61M to $4.15M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.